To: Scott Ferguson who wrote (304 ) 8/25/1998 12:44:00 AM From: Hectorite Read Replies (1) | Respond to of 450
Merrill's downgrade was based on reduced operating earnings primarly >from Thermo Instrument's Thermo Quest sub. I can't get making out TMQ as the scapegoat. They (TMQ management) said getting orders late was what screwed up the quarter. They didn't put a number on that directly, but said receivables went up maybe to the tune of $7M revenue. That hurts TMQ with revenue of ca. 100M, but doesn't seem like it should tank TMO raking in almost a billion (revenue) a quarter.Also mentions that TMO is seeking a large biomedical acquisition, but that nothing on this front has happened or appears to be happening any time soon. That's really got to be the crux of the matter. Got any ideas on the "real" internal growth of TMO? I'd wager it's mid single digits. Now they're big enough that messing around letting tiny subs (by comparison) buy-up still smaller companies just doesn't add anything to the bottom line. "Victim of own success" syndrome? I'm impressed they've kept it up this long! I bought in over two years ago at about $42, having been Well, if you believe as I do the stocks take a *long* time to get out of the doghouse in this market, you could realize the loss for tax purposes and buy back in 30 days. Stock could go up to 20+(42-20)*.3=26 and you'd still be ahead. It's a gamble, but without a major positive announcement, and earnings not due out till october, I'd be comfortable with it. Or, (and I'm not sure if you could get an IRS auditor to go along!) you could sell tmo and buy thi. They been joined at the hip forever, so you would pretty much catch any unexpected upside (or downside!) that way. just my thoughts...not advice.